AR054251A1 - Vacuna de toxoide de c. perfringens alfa - Google Patents

Vacuna de toxoide de c. perfringens alfa

Info

Publication number
AR054251A1
AR054251A1 AR20060101501A ARP060101501A AR054251A1 AR 054251 A1 AR054251 A1 AR 054251A1 AR 20060101501 A AR20060101501 A AR 20060101501A AR P060101501 A ARP060101501 A AR P060101501A AR 054251 A1 AR054251 A1 AR 054251A1
Authority
AR
Argentina
Prior art keywords
perfringens
alfa
vaccines
toxoid vaccine
type
Prior art date
Application number
AR20060101501A
Other languages
English (en)
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36820082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR054251(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of AR054251A1 publication Critical patent/AR054251A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente describe vacunas que comprenden toxoides de C. perfringens alfa de un Tipo, sus fragmentos antigénicos, fragmentos antigénicos inactivos de toxinas alfa de un Tipo de C. perfringens, o cualquiera de sus combinaciones. La presente además describe métodos para el uso de estas vacunas en la proteccion de animales contra enfermedades clostridiales. La presente describe también métodos para la elaboracion de estas vacunas.
AR20060101501A 2005-04-18 2006-04-17 Vacuna de toxoide de c. perfringens alfa AR054251A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67228905P 2005-04-18 2005-04-18

Publications (1)

Publication Number Publication Date
AR054251A1 true AR054251A1 (es) 2007-06-13

Family

ID=36820082

Family Applications (1)

Application Number Title Priority Date Filing Date
AR20060101501A AR054251A1 (es) 2005-04-18 2006-04-17 Vacuna de toxoide de c. perfringens alfa

Country Status (25)

Country Link
US (2) US8980283B2 (es)
EP (1) EP1874344B1 (es)
JP (2) JP5243951B2 (es)
KR (1) KR20080005277A (es)
CN (1) CN101198352B (es)
AR (1) AR054251A1 (es)
AU (1) AU2006236365B2 (es)
BR (1) BRPI0610843B1 (es)
CA (1) CA2606180C (es)
CR (1) CR9443A (es)
DK (1) DK1874344T3 (es)
ES (1) ES2583484T3 (es)
IL (1) IL186701A0 (es)
MA (1) MA29406B1 (es)
MX (1) MX2007013053A (es)
MY (1) MY149604A (es)
NZ (1) NZ562637A (es)
PE (1) PE20061398A1 (es)
RU (1) RU2434638C2 (es)
SG (1) SG186672A1 (es)
TN (1) TNSN07387A1 (es)
TW (1) TWI311057B (es)
UA (1) UA98099C2 (es)
WO (1) WO2006113772A1 (es)
ZA (1) ZA200709516B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY149604A (en) * 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
WO2007126816A2 (en) * 2006-03-30 2007-11-08 Embrex, Inc. Methods and compositions for vaccination of poultry
US7732187B2 (en) 2006-04-17 2010-06-08 Intervet Inc. Recombinant attenuated clostridium organisms and vaccine
CA2667255A1 (en) 2006-10-27 2008-05-08 Dow Agrosciences Llc Poultry vaccine, for necrotic enteritis, comprising a mutated clostridium perfringens alpha toxin antigen, and methods of producing the vaccine
EP2086578B1 (en) * 2006-11-20 2012-01-11 Intervet International B.V. Use of clostridium perfringens type c bacterium for the manufacture of a vaccine
CA2629790C (en) * 2007-04-12 2015-06-30 Nutratech Use of avian anti-methanogen antibodies for reduction of methane production
WO2009000066A1 (en) * 2007-06-22 2008-12-31 University Of Guelph Vaccine against clostridium perfringens
US8956628B2 (en) * 2007-12-13 2015-02-17 Zoetis Products Llc Bacteriophage preparations and method of use thereof
US8293101B2 (en) 2009-03-13 2012-10-23 Terrasep, Llc Methods and apparatus for centrifugal liquid chromatography
WO2011103465A2 (en) * 2010-02-20 2011-08-25 Alexey Gennadievich Zdanovsky Botulinum neurotoxin antigenic compositions and methods
WO2011151941A1 (ja) * 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
CN102008720B (zh) * 2010-07-20 2015-02-25 东北农业大学 抗魏氏梭菌病转基因植物疫苗及其制作方法
US20140377248A1 (en) * 2011-12-23 2014-12-25 Merz Pharma Gmbh & Co. Kgaa Method for the manufacturing of di-chain proteins for use in humans
CN102657683B (zh) * 2012-06-02 2014-05-07 哈尔滨工业大学 一种免疫类毒素的制备方法
CN102698259B (zh) * 2012-06-12 2017-02-08 北京中海生物科技有限公司 一种鸡坏死性肠炎（a型）灭活疫苗制备方法
CN102688484B (zh) * 2012-06-13 2016-03-30 北京中海生物科技有限公司 一种鸡坏死性肠炎（c型）灭活疫苗的生产方法
PL2911688T3 (pl) 2012-10-26 2020-03-31 Intervet International B.V. Szczepionki zapewniające ochronę krzyżową przeciwko salmonelli
CN103463632B (zh) * 2013-09-05 2016-01-06 山东农业大学 牛羊肠毒血症的d型产气荚膜梭菌类毒素疫苗的制备方法
FR3012964A1 (fr) * 2013-11-12 2015-05-15 Seppic Sa Vaccins adjuves pour vaccination aviaire in ovo
CN103861094A (zh) * 2014-03-27 2014-06-18 山东农业大学 一种产气荚膜梭菌α毒素基因工程疫苗及其应用
CN104131022A (zh) * 2014-08-01 2014-11-05 中国农业科学院兰州兽医研究所 产气荚膜梭菌α、β1、β2、ε毒素共表达载体及其构建方法和表达方法
CN104531730B (zh) * 2014-12-15 2018-07-17 中国人民解放军军事医学科学院军事兽医研究所 产气荚膜梭菌α毒素人源化单链抗体8B
CN104531731B (zh) * 2014-12-15 2018-06-26 中国人民解放军军事医学科学院军事兽医研究所 产气荚膜梭菌α毒素人源化单链抗体7D
CN104531867B (zh) * 2014-12-25 2017-03-29 湖北省农业科学院畜牧兽医研究所 产气荚膜梭菌肠毒素阳性菌双重荧光定量pcr快速检测试剂盒
EP3112474A1 (en) * 2015-06-29 2017-01-04 Evonik Degussa GmbH Method of detecting avian necrotic enteritis
MA47317A (fr) 2017-01-23 2019-11-27 Univ Florida Induction d'immunité protectrice contre des antigènes
JP7161729B2 (ja) * 2017-02-28 2022-10-27 一般財団法人阪大微生物病研究会 多価ワクチン
EP3630800A4 (en) * 2017-05-31 2021-03-24 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food VACCINE AGAINST NECROTIC ENTERITIS IN POULTRY
WO2018224595A1 (en) * 2017-06-09 2018-12-13 Hipra Scientific, S.L.U. Vaccine comprising clostridium toxoids
US11596677B2 (en) * 2017-08-04 2023-03-07 University Of Florida Research Foundation, Incorporated Induction of protective immunity against antigens
CN107596361B (zh) * 2017-09-12 2020-08-14 浙江海隆生物科技有限公司 牛a型产气荚膜梭菌的亚单位疫苗及其制备方法和应用
CN107875377B (zh) * 2017-11-06 2020-01-03 山东农业大学 一种e型产气荚膜梭菌类毒素疫苗的制备方法
CN109954135B (zh) * 2017-12-25 2023-01-31 金宇保灵生物药品有限公司 牛a型产气荚膜梭菌灭活类毒素疫苗及其制备方法
CN108578686B (zh) * 2018-04-23 2022-07-01 杨凌凯瑞生物科技有限公司 一种制备羊梭菌病基因工程亚单位疫苗的方法
CN109111509B (zh) * 2018-09-19 2021-08-13 天康制药(苏州)有限公司 腐败梭菌α毒素突变体、表达其的基因、制备方法和腐败梭菌疫苗
CN111500482B (zh) * 2019-01-31 2023-09-05 内蒙古金宇保灵生物技术研究院有限公司 一种羊a型产气荚膜梭菌菌株及其灭活疫苗和疫苗制备方法
CN109943507B (zh) * 2019-03-26 2021-08-17 中国兽医药品监察所 一种兽用a型产气荚膜梭菌类毒素的制备方法及其应用
CN110041437B (zh) * 2019-04-29 2020-12-25 中国兽医药品监察所 一种无毒性破伤风毒素和诺维梭菌α毒素重组融合蛋白

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2257230B1 (es) 1973-09-14 1976-11-19 Agronomique Inst Nat Rech
SU627610A1 (ru) * 1977-09-30 1980-02-05 Zemlyakova V P Препарат землаково в.п. против клюстридиозов животных и птиц
ES2185631T3 (es) 1992-05-20 2003-05-01 Secr Defence Vacunas de clostridium perfringens.
DE69432665T3 (de) * 1993-03-29 2007-12-06 Pfizer Inc. Multikomponentenimpfstoff aus clostridien, der saponin als adjuvans benutzt
US6048535A (en) 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
ATE526033T1 (de) 2002-05-21 2011-10-15 Schering Plough Ltd Verfahren für die kultur von sporozoea sp. in vitro und ihre anwendungen
EP1639109B1 (en) 2003-06-09 2011-04-13 Corixa Corporation Dna vectors
CA2535618A1 (en) 2003-08-14 2005-02-24 Merial Limited Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen
WO2006041933A2 (en) 2004-10-05 2006-04-20 Diversa Corporation Improved vaccines
MY149604A (en) * 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
EP2086578B1 (en) 2006-11-20 2012-01-11 Intervet International B.V. Use of clostridium perfringens type c bacterium for the manufacture of a vaccine

Also Published As

Publication number Publication date
PE20061398A1 (es) 2007-01-15
CN101198352A (zh) 2008-06-11
CA2606180C (en) 2016-09-13
CA2606180A1 (en) 2006-10-26
TNSN07387A1 (en) 2009-03-17
EP1874344B1 (en) 2016-06-08
BRPI0610843B1 (pt) 2021-11-30
JP2012062330A (ja) 2012-03-29
IL186701A0 (en) 2008-02-09
RU2434638C2 (ru) 2011-11-27
JP2008536936A (ja) 2008-09-11
TWI311057B (en) 2009-06-21
TW200719910A (en) 2007-06-01
KR20080005277A (ko) 2008-01-10
AU2006236365A1 (en) 2006-10-26
MA29406B1 (fr) 2008-04-01
RU2007142337A (ru) 2009-05-27
SG186672A1 (en) 2013-01-30
UA98099C2 (uk) 2012-04-25
DK1874344T3 (en) 2016-09-19
US8980283B2 (en) 2015-03-17
JP5243951B2 (ja) 2013-07-24
ES2583484T3 (es) 2016-09-21
CR9443A (es) 2008-02-20
WO2006113772A1 (en) 2006-10-26
AU2006236365B2 (en) 2012-02-02
US9662380B2 (en) 2017-05-30
CN101198352B (zh) 2011-07-27
ZA200709516B (en) 2008-11-26
EP1874344A1 (en) 2008-01-09
US20060233825A1 (en) 2006-10-19
NZ562637A (en) 2010-06-25
MY149604A (en) 2013-09-13
US20150140033A1 (en) 2015-05-21
BRPI0610843A2 (pt) 2010-07-27
MX2007013053A (es) 2008-01-14

Similar Documents

Publication Publication Date Title
AR054251A1 (es) Vacuna de toxoide de c. perfringens alfa
CL2019003636A1 (es) Polinucleótidos de aadc para el tratamiento de la enfermedad de parkinson.
ECSP099079A (es) Mimeticuerpos de peptido-1 similar a glucagon de humano, composiciones, metodos y usos
CR11122A (es) Vacuna de influenza de emulsion de aceite en agua
BRPI0510430A (pt) composições e métodos para vacinação mucosal
BRPI0509528A (pt) corpos imitação de glp-1 humana, composições, processos e usos
CR10726A (es) Vacuna que comprende un adyuvante de emulsion de aceite en agua
BRPI0509606A (pt) emulsões de óleo-em-água microfluidizadas e composições para vacinas
NI200700158A (es) Agonistas glp-1, composiciones, métodos y usos
CL2012003281A1 (es) Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica.
NI201000056A (es) Anticuerpos anti-amiloides, composiciones, métodos y usos.
CR20130016A (es) ANTICUERPOS PEPTIDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
AR025750A1 (es) Vacunas
RS52188B (en) A PSYCHI VACCINE FOR THE PROTECTION OF ERLIHIOSIS
AR060565A1 (es) Vacuna para la gripe aviaria y metodos de uso
BRPI0812856A2 (pt) Composições de vacina de emulsão que compreendem antígeno e adjuvante na fase aquosa.
BR112013005136A2 (pt) composições e métodos para controlar pragas de nematodeo
GT200500094A (es) Formulaciones liquidas administrables pro via dermica para combatir artropodos parasitos en animales
PH12015501875A1 (en) Acellular pertussis vaccine
BRPI0518571A2 (pt) peptÍdeos de alfa timosina como adjuvantes de vacina contra cÂncer
MX2016001695A (es) Composiciones inmunogenas de combinacion.
BR112019004303A2 (pt) composição de conjugados multivalentes de polissacarídeo capsular pneumocócico-proteína portadora e uso da mesma
GT200600106A (es) Agentes endoparasiticidas
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso

Legal Events

Date Code Title Description
FC Refusal